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The nanocomposites of piroxicam and meloxicam with alumina were obtained by ball-milling as a result of
distribution of the drugs at the surface of oxide with formation of the stable composites. The observed changes in
the IR spectra of the ball-milled mixtures suggested the interaction of the drugs with the alumina active surface
sites. The functional groups in molecules of piroxicam and meloxicam involved into formation of bonds between the
drugs and the surface of the oxide were determined, they are amide, sulfate, enol groups, and pyridyl / thiazolyl
nitrogen atoms. It appears that the formation of the new bonds at the contacts of particles in the composite
leads to the stabilization of the drugs in metastable state inhibiting their transformation into initial crystalline form.
PACS: 62.25.–g
1. Introduction
The attention of many researches has turned to the
studies of the systems based on organic-inorganic hy-
brids. A growing interest is attributed to the diverse
properties of such systems [1]. These systems repre-
sent hybrid core-shell particles with unique properties
and could widely been used in many areas of technolo-
gies including pharmacy. Nowadays, the technology pro-
vides many approaches to obtain such systems and the
mechanochemical methods can be regarded as attrac-
tive eco-friendly alternative route, which allows us to de-
crease the synthesis temperature and avoid or decrease
the amount of organic solvent used.
Although mechanical treatment of the systems includ-
ing two or more solid components is widely used in a
wide range of practical applications to prepare new mate-
rials with desirable properties (solubility, catalytic activ-
ity, etc.), little is known about process mechanisms and
phase interactions in solids induced by this treatment [2].
In turn, investigations of chemical reactions in molecular
solids that occur during mechanical action, including the
interactions between drug and excipient is of great inter-
est for pharmacy [3, 4], because control of these reactions
allows to increase stability and bioavailability of drugs.
∗ corresponding author; e-mail: shah@solid.nsc.ru
Different methods such as vibration spectroscopic meth-
ods, thermal analysis studies, nuclear magnetic resonance
spectroscopy and some others are widely used to charac-
terize these interactions [3–7]. To the best of our knowl-
edge, X-ray photoelectron spectroscopy (XPS) has never
been used before for characterization of drug-excipient
systems.
The present study is aimed at the preparation of hy-
brid organic-inorganic composites of drugs, piroxicam
and meloxicam, with alumina by mechanochemical meth-
ods, and at the investigation of the interaction between
the components by the IR spectroscopy and high resolu-
tion XPS methods.
Piroxicam and meloxicam (Fig. 1) are non-steroidal
anti-inflammatory drugs poorly soluble in water. It is
well known [8] that mechanical treatment of drugs with
excipients is an efficient method to prepare solid dis-
persions of drugs with controlled drug release and sol-
ubility. Usually, water soluble carriers (such as natu-
ral and synthetic polymers, salts of metals, etc.) are
widely employed for obtaining solid dispersions with en-
hanced dissolution rate and solubility of the drug by
mechanochemical methods, and in case of non-soluble or-
ganic or inorganic excipients, for example inorganic ox-
ides, an effective concentration can be maintained over a
longer period of time, so controlled release rate could be
achieved [9, 10]. This is also important for development
of the target drug delivery systems.
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Fig. 1. Piroxicam (a) and meloxicam (b) molecular
structures.
Highly dispersed alumina is used as a catalyst carrier
and as a sorbent in different fields of technique. It was of
great interest to use alumina as a model system for immo-
bilization of organic drugs by mechanochemical methods
for further investigation of interaction between drugs and
inorganic oxides.
2. Experimental Details
Piroxicam was synthesized at Irkutsk Institute of
Chemistry (Irkutsk, Russia) according to an original
technology [11]. Meloxicam was purchased from JSC
Altaivitaminy (Biisk, Russia). Gamma alumina (S =
355 m2/g) was prepared at Boreskov Institute of Catal-
ysis (Novosibirsk, Russia) according to an original pilot
technology [12].
The drug-oxide mixtures (1:1 and 1:3, w/w) were ball-
milled on air in the stainless steel vials using an AGO-2
planetary centrifugal mill with water-cooled vials. A ball
diameter of 6 mm and the 1:30 ratio of sample mass to
the mass of balls were used. Vial volume of 40 ml, and
load per ball of 20 g were employed. Time of treatment
was 15 and 30 min.
Electron microscopy photographs of the samples were
taken using JEM2000-FX electron microscope (JEOL,
Japan) cooling the sample with liquid nitrogen. X-
ray powder diffraction patterns were measured with a
D8 DISCOVER GADDS diffractometer (Bruker) with
CuKα-radiation, 2θ = 5 ÷ 45. Attenuated total re-
flectance (ATR) infrared spectroscopy was performed
with Digilab Excalibur 3100 FTIR spectrometer (Var-
ian) without special preparation of the samples, spectral
resolution was better than ±2 cm−1.
The XPS analyses were performed on a SPECS pho-
toelectron spectrometer (Germany) with MgKα X-ray
source (1253.6 eV). The samples were attached to the
holder with the help of a double-sided adhesive tape.
Prior to the analysis the samples were outgassed under
vacuum for 24 h, the spectra were obtained at a pressure
of ∼ 5 × 10−9 Torr. Each analysis started with a sur-
vey scan from 0 to 1100 eV with 1 sweep. For the high
resolution analysis the number of sweeps was increased.
Pass energy was of 20 eV during recording all the spec-
tra. Voltage in increments was of 0.05 eV. The scale
of binding energy of the spectrometer was preliminarily
calibrated on the basis of the lines of gold and copper,
Au4f7/2 (84.0 eV) and Cu2p3/2 (932.6 eV). The values of
binding energies of photoelectron peaks were determined
with the accuracy of ±0.1 eV. Spectra of non-conducting
samples were calibrated on the basis of the C1s line (284.8
eV). The “Flood gun” neutralization system was used to
remove the surface charge. The normalization of intensi-
ties was performed. Deconvolution of spectral lines into
components was made using “XPS Peak” software pack-
age.
3. Results and discussion
3.1. Composites of piroxicam with alumina
Piroxicam used in the work is a crystalline modifica-
tion I(β), the NH groups are hydrogen bonded with SO2
groups forming dimers [13]. Recently [9, 10], upon co-
grinding in AGO-2 mill, X-ray amorphous product was
obtained for the 1:3 piroxicam - alumina mixture (Fig. 2).
It was assumed that the drug was nanodispersed at the
surface of the oxide forming the stable composites. Un-
der subsequent heating of the samples obtained the crys-
tallization of the drug was not detected. Also the yellow
color of the ball-milled piroxicam-oxide mixtures was pre-
served on heating, confirming that piroxicam was present
as zwitterions in the composites [14, 15].
It is seen from the Fig. 3 that upon ball-milling, alu-
mina particles change their morphology, but their size re-
mains in the nanoscale region. The presence of the drug
in the mixture results in less change in the morphology of
particles, than in the case of pure oxide. Thus, particles
morphology changes into fine rods about 2-5 nm thick
and the particles are less aggregated after milling than
those in the case of pure oxide.
Fig. 2. X-ray powder diffraction patterns of piroxicam
and its mixtures with Al2O3: 1 – piroxicam initial, 2 -
Al2O3 initial, 3 – 1:1 piroxicam - Al2O3 mixture ball-
milled for 15 min, 4 – the same mixture ball-milled for
30 min, 5 - 1:3 piroxicam - Al2O3 mixture ball-milled
for 15 min, 6 – the same mixture ball-milled for 30 min.
The IR spectra of the ball-milled piroxicam and
piroxicam-Al2O3 mixtures change in comparison with the
spectra of the initial drug (Fig. 4, Table I) [9, 10]. The
spectrum of initial piroxicam coincided with that avail-
able in Ref. [16]. The bands of piroxicam metal com-
plexes are shown for a comparison in Table I, since it
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Fig. 3. Electron-microscopy photos of initial (a) and
ball-milled (b) alumina, ball-milled mixtures of alumina
with piroxicam (c) and meloxicam (d).
Fig. 4. ATR spectra of initial piroxicam (1), 1:1 pirox-
icam – Al2O3 mixture ball-milled for 15 (2) and 30 (3)
min and 1:3 piroxicam – Al2O3 mixture ball-milled for
15 (4) and 30 (5) min.
has been demonstrated [16, 17] that for several bivalent
metal ions piroxicam is a strong chelator via the amide
oxygen atom and nitrogen atom from the pyridyl ring.
In the IR spectra of ball-milled piroxicam, except for
3337 cm−1 absorption, a band at 3380 cm−1 appears. It
has been supposed [15] that this new band in the N-H
stretch region corresponds to a second N-H bond, sug-
gesting the formation of piroxicam zwitterion form as
a result of proton transfer from enolate O-H group to
the basic pyridine N. On the other hand, the well de-
fined peaks at 3396 and 3340 cm−1 in the spectrum of
piroxicam can be assigned to the ν(N-H) and ν(O-H)
vibrations, respectively [16]. In the spectra of piroxi-
cam metal complexes, the strong ν(O-H) peak at 3340
cm−1 disappeared supporting the deprotonation of the
enol group [16, 17]. In our case, as a carrier content
and the time of mechanical treatment increased, the ab-
sorption at 3340 cm−1 decreased and that at 3380 cm−1
increased. Indeed, this may be caused by zwitterion for-
mation, its concentration might be higher when alumina
is used as a carrier. Supporting this, the marker bands of
zwitterion (1465 and 1400 cm−1) [18] are observed in the
spectrum of the composite, a broad band in the region
of 3350-3200 cm−1 indicated the formation of zwitterion
also [19]. Besides, interaction of enol group with hydroxyl
groups at the surface of alumina may lead to hydrogen
bonding or dehydroxylation that results in a decrease in
the ν(O-H) absorption.
In the IR spectra of piroxicam – alumina composites,
carbonyl absorption band at 1630 cm−1 shifts to lower
frequencies in comparison with the spectra of intact and
ball-milled piroxicam. It has been proven [16] that the
shift of this band in the spectra of piroxicam Cu(II) and
Ni(II) complexes results from a strong metal coordina-
tion to the amide oxygen atom of the drug. The amide
II band, which in secondary amides is a mixed motion
involving the N-H in-plane bending and the C-H stretch-
ing vibration, is also slightly shifted to lower frequencies
in the composite as it was observed in the complexes.
The band at 1530 cm−1, which involves C=N stretch-
ing vibrations, does not change in the ball-milled pirox-
icam, whereas in the composite, it is splitted into two
bands, similarly to what has been observed in complex
compounds. The amide III band involving ν(C-N) and
δ(NH) combination is found in practically the same po-
sition for ball-milled piroxicam and composite, as well as
for intact piroxicam. This band was absent in the spectra
of the metal complexes [16]. The bands corresponding to
antisymmetric (1350 cm−1) and symmetric (1180 cm−1)
stretching vibrations of the SO2 group are not related to
a metal bonding in the complexes, nevertheless, it has
been shown [16, 17] that they shifted to lower or higher
frequencies, probably due to hydrogen bonding effects.
In the piroxicam – alumina composite, these bands lose
intensity and 1180 cm−1 band is splitted into two ones,
at 1184 and 1171 cm−1.
In general, the changes in the IR spectra of piroxicam
can be caused by amorphization of the drug, by trans-
formation of piroxicam into zwitterion form, and also by
the interaction of the drug with the carrier. The γ-Al2O3
used in the work was shown [12] to contain surface Brön-
sted acid sites representing by terminal and bridged OH
groups and strong Lewis acid sites generated by coor-
dinatively unsaturated surface alumina ions. Besides,
bridging oxygen atoms (Al-O-Al) and oxygen atoms in
OH groups (Al-OH) behave as surface basic sites. These
surface active sites can serve as the centers for bonding
with the drug functional groups. The similarity of IR
spectra of piroxicam – alumina mechanocomposites and
piroxicam metal complexes suggests that in the compos-
ites, piroxicam carbonyl oxygen and the pyridyl nitrogen
atoms can bind to the surface alumina ions. Neverthe-
less, it is difficult to unambiguously conclude about SO2
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group interactions, because the changes in the spectra
can be caused also by some other reasons.
Figure 5, a shows the XPS survey spectra for physical
and ball-milled piroxicam – alumina mixtures. The XPS
spectrum of piroxicam is, as far as we know, reported
here for the first time.
Fig. 5. XPS survey spectra for 1:3 piroxicam (a) –
meloxicam, (b) – alumina mixtures: 1 – physical mix-
ture, 2 – ball-milled mixture.
The core lines are assigned according to Ref. [20]. For
a physical mixture, the spectrum is a superposition of the
core lines of initial components. The intensity of piroxi-
cam lines is not so high compared to alumina, probably
due to rather large size of piroxicam particles. In the case
of ball-milled mixture, the relative intensity of piroxicam
lines increases that can be explained by the formation of
core-shell composite resulting in increasing the surface of
the organic phase. The C1s core-level binding energies of
ball-milled piroxicam (Fig. 6a) do not change, suggesting
that carbon framework is not destroyed under mechani-
cal treatment. Changes in N1s peaks (Fig. 6b) are rather
slight. It might be expected, however, that XPS spectra
should change in this region as a result of transformation
of piroxicam into zwitterion form, but these changes are
not strongly pronounced, because of a small content of
zwitterion form. Indeed, the content of zwitterion form in
cryoground piroxicam is only 8 % [15], and in the piroxi-
cam ball-milled at room temperature, it is obviously even
less. The differences in values of the binding energies of
the sulfur core lines in the spectra of the piroxicam-Al2O3
ball-milled mixtures have been detected (Fig. 6c), which
may be rationalized by the formation of bonds between
the sulfur of sulfate group of piroxicam and the active
sites at the surface of alumina. Thus, the XPS data
allow us to conclude that SO2 group takes part in the
interaction with the carrier.
Fig. 6. XPS core lines spectra for piroxicam (solid
line), ball-milled piroxicam (dash line) and ball-milled
1:3 piroxicam – alumina mixture (dash dot line): C1s a),
N1s b), S2p3/2−1/2 c).
3.2. Composites of meloxicam with alumina
As in the case of piroxicam - alumina mechanocompos-
ites, the presence of meloxicam in the mixture results in
the change in the morphology of the particles, but not sig-
nificantly. It is assumed that the drug is nanodispersed
at the surface of oxide, so that a thin layer is formed
(Fig. 3). This is confirmed by the absence of alumina
lines in the XPS survey spectrum (Fig. 5b). Indeed, as
the depth of penetration of radiation into solid in XPS
analysis is about 50 Å, we can see only the organic phase
in the spectrum.
Initial meloxicam is a crystalline form with enol
molecules directly linked into dimers by hydrogen bonds
between NH and SO2 groups, the carbonyl group is in-
volved into the formation of intramolecular hydrogen
bonds with hydroxyl group [21]. A significant decrease
in the intensities or complete disappearance of the X-ray
diffraction peaks of the drug is observed, especially as the
duration of mechanical treatment and the content of the
oxide increase (Fig. 7).
Figure 8 shows the IR spectra of initial meloxicam and
the ball-milled samples. The selected absorption data
for the samples obtained and, for a comparison, for the
meloxicam Fe(II) metal complex [22], are reported in Ta-
ble II. The changes in the ball-milled meloxicam spec-
trum suggested the formation of zwitterion form. In the
IR spectrum of 1:3 meloxicam-Al2O3 mixture (Fig. 8),
the 3290 cm−1 band, assigned to N-H stretching vibra-
tions [22], loses intensity. The carbonyl stretching vibra-
tion at 1619 cm−1 behaves the same way, in contrast to
the meloxicam Fe(II) complex, where this band shifts to
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Fig. 7. X-ray powder diffraction patterns of meloxi-
cam - alumina mixtures: 1 – 1:3 physical mixture, 2
– 1:1 physical mixture, 3 – 1:3 meloxicam–Al2O3 mix-
ture ball-milled for 30 min, 4 – 1:1 meloxicam–Al2O3
mixture ball-milled for 30 min.
higher frequencies [22]. The ν(C=N) absorption practi-
cally does not change in the spectrum of the composite.
In the CH3 deformation vibrations region [23] the inten-
sity of the 1458 cm−1 band decreases and the new bands
appear.
Fig. 8. ATR spectra of meloxicam and meloxicam –
alumina mixtures: 1 – initial meloxicam, 2 – ball-milled
meloxicam, 3 - 1:1 meloxicam–alumina physical mix-
ture, 4 - 1:1 mixture ball-milled for 15 min, 5 - 1:3
physical mixture, 6 - 1:3 mixture ball-milled for 15 min.
The νas(SO2) (1346 cm−1) and νs(SO2) (1183 cm−1)
bands are broadened in the spectrum of the composite
contrary to the meloxicam Fe(II) complex, where these
bands significantly shift to lower frequencies [22]. The
broadening of the O-H deformation vibration band at
1133 cm−1 has been also detected. These changes agree
with the expected disordering of the meloxicam crystal
structure followed by breaking the hydrogen bonds and
with the existence of the interaction between the compo-
nents in the ball-milled mixture involving amide, sulfate
and enol groups of meloxicam and alumina active surface
sites such as, for example, hydroxyl groups.
Fig. 9. XPS core lines spectra of meloxicam (solid
line), ball-milled meloxicam (dash line) and ball-milled
1:3 meloxicam - alumina mixture (dash dot line):
C1s a), N1s b), S2p3/2−1/2 c).
The XPS spectra of the initial meloxicam and ball-
milled samples are compared in Fig. 9. The XPS spec-
trum of meloxicam is reported here for the first time. As
in the case of piroxicam, no changes in the C1s (Fig. 9a)
binding energies under ball milling are observed. After
ball-milling meloxicam alone and meloxicam - alumina
mixture, a new N1s transition appeared (Fig. 9b) with a
binding energy intermediate between those of the initial
states. For meloxicam, this can be attributed to forma-
tion of zwitterion form and, for the composite, to inter-
action between meloxicam and active sites at the surface
of the oxide. In the XPS spectra of meloxicam, two well-
separated S2p3/2−1/2 peaks are observed (Fig. 9c). The
peak with the lowest binding energy associates with the
sulfur in thiazolyl ring, whereas the high binding energy
peak is due to the sulfur of sulfate group. The appear-
ance of a new energetic state of sulfur of sulfate group in
meloxicam-Al2O3 mixtures, intermediate between those
of initial states may be considered as a confirmation of
the formation of bonds between sulfur of sulfate group
in meloxicam and active sites at the surface of alumina.
Thus, changes in the S2p and N1s core-level binding en-
ergies in ball-milled samples in comparison with the ini-
tial ones have been observed, that can be attributed to
the presence of hydrogen or donor-acceptor bonding be-
tween sulfur- and nitrogen-containing groups of immobi-
lized compound and the surface of the oxide.
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TABLE I
IR wavenumbers for selected characteristic bands of piroxicam, ball-milled piroxicam, piroxicam in 1:3 piroxicam – Al2O3
composite, and the bands of piroxicam Cu(II) and Ni(II) complexes (cm−1).
Assignments Piroxicam Ball milled 1:3 Piroxicam – Al2O3 Cu(Pir)2(H2O)2 Ni(Pir)2(H2O)2
piroxicam ball-milled mixture [16] [16]
(AGO-2, 30 min)
ν(N-H), or ν(O-H) 3337 vs 3380 s, 3340 vs 3380 m, 3350–3200 m, br — —
Amide I, ν(C=O) 1631 s 1631 s 1613 s 1621 vs, br 1625 vs, br
Amide II, ν(C−N) + δ(NH) 1579 m 1579 m 1569 m 1572 vs 1576 vs
ν(C=N) 1530 vs 1530 vs 1531 s, 1500 m 1540 sh, 1527 s, 1512 s 1521 s, br
νas(SO2) 1350 vs 1350 vs 1348 s 1330 vs 1328 vs
Amide III, ν(C−N) + δ(NH) 1310 s 1311 s 1313 s, br - -
νs(SO2) 1180 vs 1180 vs 1184 s, 1171 s 1166 vs 1162 vs
s = strong, vs = very strong, m = medium, br = broad, sh =shoulder
TABLE II
IR wavenumbers of selected characteristic bands of the meloxicam, ball-milled meloxicam, meloxicam in 1:3 meloxicam – Al2O3
composite, and the bands of Fe(II) meloxicam complex (cm−1).
Assignments Meloxicam Ball-milled 1:3 Meloxicam – Al2O3 Fe(Hmel)2·4H2O
meloxicam ball-milled mixture [22]
(AGO-2, 15 min)
ν(N-H) 3290 vs 3290 vs 3290 vw —
Amide I, ν(C=O) 1620 s 1620 s 1620 w, br 1582
ν(C=N) 1531 vs 1531 vs 1531 vs *)
δ(CH3) 1458 m, 1420 vw 1458 m, 1420 vw 1458 w, 1436 w, 1420 w, 1405 vw *)
νas(SO2) 1346 s 1346 s 1350 s, br 1330
Amide III, ν(C−N) + δ(NH) 1302 m 1302 m 1302 m, br *)
νs(SO2) 1183 m 1183 m 1183 m, br 1165
δ(OH) 1133 m, 1119 m 1133 m, 1119 m 1127-1122 s, br *)
s = strong, vs = very strong, m = medium, w = weak, vw = very weak, br = broad, sh = shoulder *) data are not presented
4. Conclusion
The nanocomposites of piroxicam and meloxicam with
alumina containing the drug in X-ray amorphous state
were obtained by ball-milling as a result of distribution
of the drugs in the matrix of oxide with formation of the
stable composites. The observed changes in the IR spec-
tra of the ball milled mixtures suggested the interaction
of the drugs with the alumina active surface sites. The
interaction between the components under ball-milling
was also detected by the XPS analysis. In addition to
the IR spectroscopy data, the XPS data give informa-
tion about changes at the surface layers of the samples
allowing to evidence core-shell composite formation and
estimate the thickness of a drug film on the surface of
carrier. The functional groups in molecules of piroxicam
and meloxicam involved into formation of bonds between
the drugs and surface of the oxide were determined, they
are amide, sulfate, enol groups, and pyridyl/thiazolyl ni-
trogen atoms. It appears that the formation of the new
bonds at the contacts of particles in the composite leads
to the stabilization of the drugs in the metastable state
inhibiting their transformation into the initial crystalline
form.
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